Lars Christian Lund, PhD (he/him/his)

Postdoctoral researcher
Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
Odense C, Denmark

I obtained the degree of Cand.med. (MD) in 2015 and obtained a PhD degree in pharmacoepidemiology from the University of Southern Denmark in 2022. I am currently a postdoctoral researcher working on hypothesis-free screening for drug-safety signals.
My main interests lie in using routinely collected health data for the detection of adverse drug reactions and COVID-19 epidemiology.

Disclosure information not submitted.

Presentation(s):

• Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study in Canada, Denmark, Norway, Sweden, South Korea and Taiwan

  Tuesday, August 27, 2024
  8:15 AM – 8:30 AM CEST

• Hypereosinophilia following initiation of glucagon-like peptide 1 receptor agonists: a sequence symmetry analysis using the Danish health registries

  Tuesday, August 27, 2024
  8:45 AM – 9:00 AM CEST

• Risk of kidney stones following SGLT2i- and GLP1-RA initiation among patients with type 2 diabetes in Denmark, Norway, UK, and Taiwan: Population-based active comparator, new user cohort studies and meta-analysis

  Wednesday, August 28, 2024
  2:30 PM – 2:45 PM CEST